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Microanatomical changes in the pancreatic islet cells of streptozotocin induced
diabetic Wistar rats were studied after treatment with methanolic extracts of
Annona muricata leaves. Thirty adult Wistar rats were randomly assigned into
three groups (control, untreated diabetic group, and A. muricata-treated dia-
betic group) of ten rats each. Diabetes mellitus was experimentally induced in
groups B and C by a single intra-peritoneal injection of 80 mg/kg streptozoto-
cin dissolved in 0.1 M citrate buffer. The control rats were intraperitoneally
injected with an equivalent volume of citrate buffer. Daily intra peritoneal in-
jections of 100 mg/kg A. muricata were administered to group C rats for two
weeks. Post sacrifice the pancreases of the rats were excised and fixed in Bouins
fluid. The tissues were processed for paraffin embedding and sections of 5 µm
thickness were produced and stained with H & E, Gomori aldehyde fuchsin,
and chrome alum haematoxylin-phloxine for demonstration of the b-cells of
islets of pancreatic islets. Histomorphological and morphometric examination of
the stained pancreatic sections showed a significant increase in the number,
diameter, and volume of the b-cells of pancreatic islets of the A. muricata-treat-
ed group (5.67 – 0.184 N/1000 µm2, 5.38 – 0.093 µm and 85.12 – 4.24 µm3,
respectively) when compared to that of the untreated diabetic group of rats
(2.85 – 0.361 N/1000 µm2, 2.85 – 0.362 µm and 69.56 – 5.216 µm3, respec-
tively). The results revealed regeneration of the b-cells of islets of pancreatic islet
of rats treated with extract of A. muricata. (Folia Morphol 2010; 69, 2: 92100)
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INTRODUCTION
For a long time, it was believed that the endo-
crine pancreas belonged to a category of tissues that
were finally differentiated and irreplaceable in the
adult. This was mainly supported by the low repli-
cation rate of endocrine cells in adulthood [48]. In
the light of many recent data, this point of view has
been drastically changed, and nobody disputes to-
day that that endocrine pancreas is a plastic organ
and that b-cell mass is dynamic, especially because
of its significant capacity for adaptation to changes
in insulin demand [5]. This property has been demon-
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strated in physiological as well pathophysiologi-
cal conditions such as pregnancy [43] and obesity
[28]. Increase in b-cell mass may occur through in-
creased b-cell replication, increased b-cell size, de-
creased b-cell death, and differentiation of b-cell
progenitors (neogenesis) [19].
Diabetes mellitus is one of the most common
metabolic disorders with a worldwide prevalence
estimated at between 1% and 5% of the world po-
pulation [25]. It is estimated that in the year 2000,
171 million people had diabetes, and this is expect-
ed to double by the year 2030 [6]. Conventionally,
insulin-dependent diabetes mellitus is treated with
exogenous insulin [17] and non insulin-dependent
diabetes mellitus with synthetic oral hypoglycae-
mic agents like sulphonylureas and biguanides [42].
However, the hormone fails as a curative agent for
complications of diabetes [34], and synthetic oral
drugs produce adverse health effects [41]. Different
medicinal systems are using active plant constitu-
ents, which were discovered as natural hypoglycae-
mic medicine, and came from the virtue of tradi-
tional knowledge. Annona muricata has been found
to contain numerous bioactive compounds useful
for the management of various ailments, including
diabetes mellitus, in folkloric medicine. The manage-
ment of Diabetes mellitus depends on continuous
hypoglycaemic therapy, which may not be consis-
tently adhered to by the patient. This research there-
fore investigates whether or not extracts of A. muri-
cata could provide lasting hypoglycaemic control
through regeneration of the destroyed b-cells of the
pancreatic islets of experimentally induced diabetic
Wistar rats.
Annona muricata is a plant which belongs to the
family Annonaceae. It is a medicinal plant that has
been used as a natural remedy for a variety of ill-
nesses. Several studies by different researchers have
demonstrated that the bark as well as the leaves
have anti-hypertensive, vasodilator, anti-spasmodic
(smooth muscle relaxant), and cardio depressant
(slowing of heart rate) properties in animals [18].
Researchers have re-verified A. muricata leafs hy-
potensive properties in rats [3, 8]. Other properties
and actions of A. muricata documented by traditio-
nal uses include its use as anti-cancerous [38, 50], anti-
diabetic [51], anti-bacterial [49], anti-fungal [22], anti-
malarial, anti-mutagenic (cellular protector), emetic
(induces vomiting), anti-convulsant [36], sedative,
insecticidal, and as a uterine stimulant. It is also
believed to be a digestive stimulant, antiviral, car-
dio tonic (tones, balances, and strengthens the
heart), febrifuge (cures fever), nerviness (balances/
/calms the nerves), vermifuge (expels worms), pedi-
culicide (kills lice), and as an analgesic. Padma et al.
[40] confirmed the anti-viral activity of ethanolic
extracts of A. muricata against the Herpes simplex
virus. Extracts of A. muricata have been shown to
have anti-parasitic [7], anti-rheumatic, astringent
[12], anti-leishmanial, and cytotoxic effects [24, 30].
A. muricata has also been shown to be effective
against multi-drug resistant cancer cell lines [30, 37].
Extracts of A. muricata were also shown to be effec-
tive against the cancer cell line U973 [24], and hae-
matoma cell lines in-vitro [10]. Extracts were also
shown to be lethal to the fresh water mollusc,
Biomphalaria glabrata, which acts as a host to the
parasitic worm Schistosoma mansoni [12, 31].
Streptozotocin-induced hyperglycaemia in rats
is considered a good model for the preliminary
screening of agents active against type 2 diabetes
[23] and is widely used. Generally, destruction of
b-cells starts three days after streptozotocin (STZ)
administration and reaches its peak at three to four
weeks in rats [2]. Streptozotocin-induced diabetes
in laboratory animals has been widely used for re-
search on diabetes and its long-term complications.
Control animals in these studies are usually injected
with citrate buffer solution. Streptozotocin is a po-
tent DNA methylating agent and acts as a nitric oxi-
de donor in pancreatic islet cells. Although the
b-cell cytotoxic action of STZ is not fully understood,
it is thought to be mediated by the inhibition of
free radical scavenger enzymes, thereby enhancing
the production of superoxide. The latter has been
implicated in lipid oxidation, DNA damage, and sulf-
hydryl oxidation.
MATERIAL AND METHODS
Plant material
Leaves of Annona muricata (family: Annonaceae)
were collected from Mowe, Ogun State, Nigeria in
February 2006. The leaves were botanically identi-
fied by a taxonomist in the Department of Botany
of Obafemi Awolowo University, Ile-Ife, and a vouch-
er specimen was deposited in the Universitys Bota-
ny Department Herbarium.
Preparation of methanolic extract of
Annona muricata leaves
A. muricata leaves were air dried at room tem-
perature for two weeks. The air-dried leaves were
powdered in a warring blender (Christy and Norris
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 47362, England) at the Department of Pharma-
cognosy of Obafemi Awolowo University, Ile Ife. Then
600 g of the powdered leaf was macerated in 5 li-
tres of 70% methanol for 72 hours at room temper-
ature. The mixture was filtered, and the filtrate was
concentrated in vacuo at 35oC using a vacuum rota-
ry evaporator (RE 100B, Bibby Sterilin, United King-
dom). The wet residue was freeze-dried using a vacu-
um freeze drier (FT33  Armfield, England) and was
stored until use. The percentage yield of extraction
was calculated as follows:
Care and management of animals
Thirty healthy adult Wistar rats (Rattus norvegi-
cus) weighing between 150 g and 250 g were used
for the experiment. They were kept in individual cag-
es under natural light and dark cycles at room tem-
perature. They were maintained on standard rat
pellet (Ladokun feeds, Ibadan, Nigeria) and water
given ad libitum. The animals were randomly as-
signed into three groups (A, B, and C) of ten rats
each. Group A was the control, non-diabetic group
of rats, group B was the experimentally induced dia-
betic group without A. muricata treatment, while
group C was the experimentally induced diabetic
group treated with methanolic extracts of A. muri-
cata. There was a pre-experimental period of four
weeks during which the body weight and blood glu-
cose levels were monitored in the animals before
the commencement of the experiment. The rats re-
ceived humane care according to the criteria out-
lined in the Guide for the Care and Use of Laborato-
ry Animals prepared by the National Academy of
Sciences and published by the National Institutes of
Health [35].
Acute toxicity testing
The median lethal dose (LD50) of A. muricata leaf
extract was determined in mice using the method
of Abdel-Barry et al. [1]. The mice fasted for 16 hours
and were randomly divided into 6 groups of 10 mice
each. Graded doses of PNE (20, 50, 100, 200, 400,
and 600 mg/kg) were separately administered in-
traperitoneally (ip) to the mice in each of the test
groups. The extract was dissolved in distilled water,
and the average volume injected was 0.3 mL. Each
of the mice in the control group was given an equi-
valent volume of the distilled water used in dissolv-
ing the extract. The mice in both the test and con-
trol groups were allowed free access to food and
water. The mortality in each cage was assessed
24 hours, 48 hours, and 72 hours after administra-
tion of the extract. The percentage mortality in each
group was calculated and plotted against the log10
of the extract dose. A regression line was fitted by
the method of least squares, and confidence limits
for the lethal dose (LD50) values were calculated by
the method of Abdel-Barry et al. [1].
Induction of experimental diabetes and
Annona muricata extract administration
Diabetes mellitus was induced in the rats in
groups B and C by a single intraperitoneal injection
of STZ (80 mg/kg body weight) dissolved in 0.1 M
sodium citrate buffer (pH 6.3) [3], while group A
control rats were injected with volumes of the cit-
rate buffer equivalent to the volume of STZ admin-
istered intraperitoneally. Diabetes was allowed to
develop and stabilize in these STZ-treated rats over
a period of 48 hours. The rats were fasted overnight
(16 h) but still allowed free access to water before
STZ administration. The daily body weight and the
weekly blood glucose levels were monitored in the
animals for the next four weeks. After four weeks of
experimental-induction of diabetes, group C rats
were given daily intraperitoneal injections of 100 mg/
/kg of extracts of A. muricata dissolved in distilled
water for two weeks, and the animals were moni-
tored for another four weeks.
Determination of body weight and
blood glucose level
The body weights of the animals were measured
using a top loader weighing balance. Blood sam-
ples were obtained from the tail vein of the animals
and their fasting blood glucose level was determined
in mmol/L using a digital glucometer (Accu-chekfi
Advantage, Roche Diagnostic, Germany). The ani-
mals were fasted for a period of 16 hours before
their blood glucose levels were measured.
Surgical procedures
A mid-line incision was made through the ante-
rior abdominal walls of the rats under slight anaes-
thesia using sodium pentobarbital (6.4 mg/100 g
body weight i.m.), and the pancreatic tissues were
excised and weighed after the fat and lymph nodes
had been removed. The pancreas is located at the
junction of the supra-colic and infra-colic compart-
ments of the abdominal cavity as it extends trans-
versely across the posterior abdominal wall between
the duodenum on the right and the hilum of the
Percentage Yield = ---------------------------------------------------  · 100%
weight of extract
weight of the powdered
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spleen on the left; the pancreas was isolated from the
surrounding organs and weighed. The relative weight
(%) was calculated from the body weight at sacrifice
and the absolute pancreatic weight as follows:
Histological procedure
The splenic part of the pancreas of each rat was
fixed in Bouins fixative for 24 hours and processed
via the paraffin wax embedding method of Drury
and Wallington [13]. Paraffin-embedded sections
were cut at 5 µm and stained with haematoxylin
and eosin (HE), Gomori aldehyde fuchsin, and
chrome alum haematoxylin phloxine for light micro-
scopic examination of the pancreatic islets archite-
cture. The sections were examined under a Carl Zeiss
research microscope (Axioskope 40, Germany) with
a digital camera attached. Digital photomicrographs
of the pancreatic sections were taken at various
magnifications.
Histomorphometric analysis
All histomorphometric studies were carried out
on an Olympus research microscope (Olympus
WF10X, Japan) with a linear scale-ocular microme-
ter and an area-measuring ocular grid inserted into
the eyepiece. The ocular micrometer and the ocular
grid were calibrated with a 1 mm stage micrometer
(Graticles Tonbridge, Kent, England). Twenty-four
histological stained sections (eight from each group)
were used for morphometric analysis; 202 islet pro-
files were examined at different magnifications in
the non-serial pancreatic sections to estimate
(a) the number of islets in each section of the pancreas,
(b) the area of the pancreatic tissue section, (c) the
area of the pancreatic islet, (d) the diameter of the
islets, (e) the number of b-cells of the pancreatic is-
lets, and (f) the diameter of b-cells of the pancreatic
islets. The islet area was measured in each pancre-
atic section at 400· magnification using the area-
calibrated ocular grid. The number of islets and the
area of pancreatic tissue were quantified in these
sections at 40· magnification using the ocular grid.
The number of islets was expressed as N/10 mm2 of
the pancreatic parenchyma. The b-cell profiles were
determined by direct counting method at 1000·
magnification using the ocular grid, and the point
counting method of Weibel [52] was used to esti-
mate the numerical density of the b-cells per 1000 µm2
of the islet profile (N/1000 µm2). With an ocular mi-
crometer and a graticule of a calibrated linear scale,
the major axis (a) and minor axis (b) at right angles
to the major axis of the islets were measured. The
profile diameter of the islets (Di) was calculated from
the equation Di = √ab [54].
Similar steps were followed to measure the dia-
meter (Dn) of the b-cells. A total of 150 b-cells were
measured at a magnification of 1000· (50 from
each group). The mean corrected islet diameter (Di)
and the mean corrected nuclear diameter (Dn) were
used to calculate the mean islet volume and mean
nuclear volume [54].
Statistical analysis
The data were analysed using descriptive and
inferential statistics. All values are presented as mean
– standard error of mean (SEM) for ten rats in each
of the three group of rats. The significance of differ-
ence in the means of all parameters reported for
the three groups of animals was determined using
paired sample student t-test, and a p-value of
< 0.05 (two tailed) was considered as significant.
RESULTS
Physical observation
Prior to STZ administration, there was no significant
difference in the average weights of all the rats in the
three groups. By the end of the first week after diabe-
tes mellitus was experimentally induced, the weights
of diabetic rats in groups B and C were significantly
reduced despite the increase in food and fluid intake in
these animals. This weight loss continued for four weeks
after STZ administration (Fig. 1). The animals manifest-
ed alopecia and poly-urea, shown by marked wetness
of the ventral body surface of the animals. However,
the weight of the animals in group C gradually increased
with treatment with extracts of A. muricata over the
period of five weeks (Fig. 1). In addition, there was an
improvement in the physical outlook of the A. muricata
treated animals over time. At the end of the experi-
ment, there was a significant increase in the body
weights of A. muricata treated diabetic rats when com-
pared to the untreated diabetic rats (Fig. 2); while no
significant difference existed between the weights of
the treated rats and the control.
Changes in the blood glucose level
Prior to STZ administration, the fasting blood
glucose levels did not differ significantly between
Relative
pancreatic = --------------------------------------------------- · 100%
weight
absolute
pancreatic weight
body weight
at sacrifice
4p
3
V = ------- · (D/2)3
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the three groups of experimental animals. Twenty-
-four hours after administration of STZ, the blood glu-
cose level was significantly higher in animals from
groups B and C. The blood glucose levels of animals
in group C gradually decreased with treatment with
extracts of A. muricata over the period of five weeks
(Fig. 3). Control rats treated with citrate buffer were
euglycaemic throughout the period of the experiment.
At the end of the experiment there was a significant
reduction in the blood glucose levels of groups C rats
compared to those of group B rats. In addition, there
was no significant difference between the blood glu-
cose level of rats in groups A and C (Fig. 4)
Changes in the pancreatic weights
The mean weights of the pancreases were sig-
nificantly higher in the control and A. muricata-treat-
ed rats than in the untreated diabetic rats. In addi-
tion, the relative ratio of the pancreas to the body
weight of the rats at sacrifice expressed as a per-
centage was significantly higher in the control and
A. muricata-treated groups of rats when compared
to the untreated diabetic rats (Fig. 5). However, there
was no significant difference between the pancre-
atic weights of the control rats and that of the rats
treated with extracts of A. muricata (Fig. 5).
Figure 1. Weekly changes in the body weight of the rats after
streptozotocin (STZ) and A. muricata extract (AME) administra-
tion; *STZ  administration; AME  administration begins;
AME  administration ends.
Figure 3. Weekly changes in the blood glucose level of rats after
streptozotocin (STZ) and A. muricata extract (AME) administra-
tion; *STZ  administration; AME  administration begins;
AME  administration ends.
Figure 2. Weight of control, untreated diabetic, and A. muricata
extract (AME)-treated diabetic rats; **statistical significant differ-
ence exists when compared with controls (p < 0.05).
Figure 4. Blood glucose level of control, untreated diabetic, and A.
muricata extract (AME)-treated diabetic rats; **statistical signifi-
cant difference exists when compared with controls (p < 0.05).
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Morphological observations
The histological appearance of the pancreatic
islet cells of the control was normal. Microscopic
examination of the pancreatic sections of the un-
treated diabetic group revealed a breakdown of
micro-anatomical features including degenerative
and necrotic changes, and shrunken in the pancre-
atic islet of Langerhans, b-cell degranulation, pyc-
notic b-cell nuclei, decreased islet cellular density,
and severe vacuolation (Fig. 6) in the islet, as well
as a severe reduction in the number of cells in the
islets; though the pancreatic acinar epithelium, and
ductal and connective tissues appeared normal. The
morphology of the pancreas of A. muricata-treat-
ed diabetic rats revealed remarkable improvement
in the islet of Langerhans. There was an increase in
the islet cellular density, with an increase in granu-
lation, but vacuolation was reduced or absent in
many islets (Fig. 6).
Morphometric analysis
The results of the morphometric analysis revealed
a significant reduction in the numerical density of is-
lets (number of islet/pancreas), islet area, islet diame-
ter, numerical density of b-cells (number of b-cells
per islet), volume of islets, and volume of b-cells in
the untreated diabetic group of rats when com-
pared with the control group. However, these morpho-
metric parameters were significantly increased in the
A. Muricata-treated rats when compared with those
of the untreated diabetic rats (Table 1).
DISCUSSION
Diabetes mellitus is a major global health prob-
lem, which is becoming an epidemic. The latest
World Health Organization publication (global bur-
den of disease) estimates diabetes in adults to be
around 173 million [53], around two thirds of these
living in developing countries [32]. It is a metabolic
disease characterized by high-blood glucose levels
resulting from defects in insulin secretion, insulin
action, or both [39]. The prevalence of diabetes
mellitus is increasing and it is expected to increase
by 5.4% by 2025 [33]. An increase in sedentary life-
Figure 6. Photomicrograph of pancreatic islet of normal (control),
untreated diabetic, and A. muricata treated diabetic rats stained
with H & E (A, B, and C respectively). Note the clusters of cen-
trally placed beta-cells and peripherally placed alpha-cells in A.
Degranulation (De) and vacuolation (V) of the pancreatic islets of
diabetic rats in B. Also note the increase in the beta-cell density
with greatly reduced vacuolation of islet in C. Bar = 4.55 µm.
Figure 5. Pancreatic weights of control, untreated diabetic, and
A. muricata extract (AME)-treated diabetic rats; **statistical signi-
ficant difference exists when compared with controls (p < 0.05).
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methods of managing this disease because of the
high mortality and morbidity arising from its atten-
dant complications and problems associated with
the use of conventional antidiabetic agents [9]. This
has led to the increasing demand for herbal pro-
ducts with anti-diabetic activity and fewer side ef-
fects [27].
Streptozotocin-induced hyperglycaemia in rats
is considered a good model for the preliminary
screening of agents active against type 2 diabetes
[23] and is widely used. Generally, destruction of
b-cells starts three days after STZ administration and
reaches its peak at three to four weeks in rats [2].
Streptozotocin-induced diabetes in laboratory ani-
mals has been widely used for research on diabe-
tes and its long-term complications. Control animals
in these studies are usually injected with citrate buff-
er solution. However, STZ is known to possess phar-
macological effects other than its diabetogenic pro-
perties [44], and extra pancreatic actions of STZ can-
not be excluded. The presence of GLUT2 in liver and
kidney might explain the long-term complications
seen with hepatic and renal tumours in rats treated
with STZ [11, 46]. Because of the extra pancreatic
effects of STZ, it can be difficult to distinguish ef-
fects secondary to diabetes from those secondary
to STZ per se. Streptozotocin is a potent DNA methy-
lating agent and acts as a nitric oxide donor in pan-
creatic islet cells. Although, the b-cell cytotoxic ac-
tion of STZ is not fully understood, it is thought to
be mediated by the inhibition of free radical sca-
venger enzyme thereby, enhancing the production
of superoxide. The latter has been implicated in li-
pid oxidation, DNA damage, and sulfhydryl oxidation.
Beta-cells are particularly sensitive to damage by
nitric oxide and free radicals because of their low
Table 1. Histomorphometric parameters of the pancreatic islet of control, untreated diabetic, and A. muricata-treated
diabetic rats
Group A (Control) Group B (STZ) Group C (STZ + A. muricata)
Number of islets/pancreas [N/10 mm2] 18.75 – 0.733a 4.79 – 0.443b 8.53 – 0.565c
Area of islets [mm2] 0.0108 – 0.0010a 0.0052 – 0.0006b 0.0069 – 0.0007a
Diameter of islets [µm] 130.79 – 12.825a 63.75 – 8.410b 97.69 – 10.702a
Number of b-cells/islet [N/1000 µm2] 10.64 – 0.733a 2.85 – 0.362b 5.67 – 0.184c
Diameter of b-cells [µm] 5.49 – 0.110a 4.92 – 0.137b 5.38 – 0.093c
Volume of islets [µm3] 1.49 · 106 – 3.953 · 105 a 2.10 · 105 – 9.493 · 104 b 6.53 · 105 – 1.989 · 105 a
Volume of b-cells [µm3] 115.29 – 6.550a 69.56 – 5.216b 85.12 – 4.24c
a, b, and c between row signify that means with different letters differ significantly at p < 0.05 two tailed t-test while means with the same
letter do not differ significantly at p < 0.05
style, consumption of energy-rich diet, and obesity
are some of the factors causing the rise in the num-
ber of diabetics. However, Asia and Africa are iden-
tified as regions with the greatest potential, where
diabetics could rise two- or threefold above the
present level [4]. In traditional African societies, phy-
totherapy is highly valued and widely utilized. The
majority of the population use plant materials as
their source of primary healthcare [15].
In modern medicine, the beneficial effects of
standard medications on glycaemic levels are well
documented; the preventive activity of these medi-
cations against the progressive nature of diabe-
tes and its complications produce reasonable re-
sult but they are not always effective. Insulin ther-
apy affords glycaemic control in type 1 diabetes,
yet its shortcomings, such as ineffectiveness on
oral administration, short shelf life, the require-
ment of constant refrigeration, fatal hypoglycae-
mia in the event of excess dosage, the reluctance
of patients to take insulin injections, and above
all the resistance due to prolonged administration,
limit its usage [26]. Similarly, treatment of type 2
diabetes patients with sulfonylureas and bigu-
anides is always associated with side effects [20].
Hence the search for a drug with low cost, great-
er potential, and no adverse side effects is under-
way in several laboratories around the world.
For various reasons, in recent years, the popular-
ity of alternative medicine has increased. Surveys
conducted in Australia and the United States indi-
cate that almost 48.5% and 34% of the respondents,
respectively, had used at least one form of uncon-
ventional therapy, including herbal medicine [14].
The WHO Expert Committee on Diabetes has also
recommended further evaluation of the folkloric
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levels of free radical scavenging enzymes [47]. In
this present study, almost all the insulin-producing
b-cells were degranulated, degenerated, or necro-
sed in the streptozotocin-treated rats, leading to
a decrease in insulin secretion and an increase in blood
glucose concentration. However, treatment with
extracts of A. muricata showed a significant antihy-
perglycaemic activity in STZ-induced diabetic rats at
the end of the experiment. It has been suggested
that bioactive compounds from plant sources ha-
ving antihyperglycaemic activities might act by se-
veral mechanisms such as stimulating insulin secre-
tion, increasing repair, or proliferation of b-cells and
enhancing the effects of insulin and adrenalin [16,
45]. The results of this present study indicate that
the decrease in the blood glucose concentration of
diabetic rats by A.muricata treatment is due to the
regeneration/proliferation in the pancreatic b-cells.
The regeneration of the b-cells of the STZ-destruct-
ed islets is probably due to the fact that pancreas
contains stable (quiescent) cells which have the ca-
pacity of regeneration. Therefore, the surviving cells
can proliferate to replace the lost cells [21, 29].
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